Robert J Kinders Selected Research

Hepatocyte Growth Factor (Growth Factor, Hepatocyte)

1/2018

Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Kinders Research Topics

Disease

45	Neoplasms (Cancer) 01/2021 - 11/2008
5	Circulating Neoplastic Cells 01/2020 - 02/2010
4	Carcinoma (Carcinomatosis) 01/2020 - 01/2015
4	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 03/2012
4	Hypoxia (Hypoxemia) 08/2014 - 07/2009
3	Lymphoma (Lymphomas) 11/2020 - 03/2012
3	Triple Negative Breast Neoplasms 01/2018 - 03/2012
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2015
2	Peritoneal Neoplasms 01/2017 - 01/2015
2	Fallopian Tube Neoplasms 01/2017 - 04/2015
2	Carcinogenesis 08/2015 - 01/2011
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Diarrhea 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Leukemia 02/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 02/2017
1	Mucositis 02/2017
1	Fanconi Anemia (Fanconi's Anemia) 02/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017
1	Fatigue 01/2017
1	Lymphopenia (Lymphocytopenia) 02/2016
1	Ovarian Epithelial Carcinoma 02/2016

Drug/Important Bio-Agent (IBA)

11	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 09/2010
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2009
10	veliparibIBA 02/2017 - 11/2008
9	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2014
9	Pharmaceutical PreparationsIBA 12/2018 - 02/2010
7	Topotecan (Hycamtin)FDA LinkGeneric 03/2018 - 07/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2010
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016 - 11/2008
4	Histones (Histone)IBA 02/2017 - 10/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 03/2012
3	birinapantIBA 03/2018 - 02/2016
3	Phosphotransferases (Kinase)IBA 01/2018 - 04/2013
3	Poly Adenosine Diphosphate RiboseIBA 01/2016 - 01/2011
3	EnzymesIBA 08/2014 - 07/2009
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2014
2	adavosertibIBA 01/2021 - 10/2015
2	Temozolomide (Temodar)FDA LinkGeneric 11/2020 - 02/2017
2	NSC 724998IBA 12/2018 - 07/2016
2	Topoisomerase I InhibitorsIBA 12/2018 - 03/2018
2	PlatinumIBA 01/2018 - 02/2016
2	AntibodiesIBA 01/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
2	Bevacizumab (Avastin)FDA Link 04/2014 - 07/2009
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2012 - 07/2009
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2011 - 09/2010
1	RNA (Ribonucleic Acid)IBA 01/2021
1	2'-deoxy-4'-thiocytidineIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	methoxyamineIBA 11/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2020
1	nilotinib FDA Link 01/2020
1	CateninsIBA 01/2020
1	TubulinIBA 01/2020
1	VimentinIBA 01/2020
1	talazoparibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	TetrahydrouridineIBA 01/2020
1	5-fluoro-2'-deoxycytidineIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	pazopanib FDA Link 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2019
1	CamptothecinIBA 12/2018
1	indimitecanIBA 12/2018
1	ParaffinIBA 03/2018
1	Cisplatin (Platino)FDA LinkGeneric 03/2018
1	Formaldehyde (Formol)FDA Link 03/2018
1	tepotinibIBA 01/2018
1	GSK 1363089IBA 01/2018
1	ARQ 197IBA 01/2018
1	cabozantinibIBA 01/2018
1	EMD1214063IBA 01/2018
1	defactinibIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 02/2017
1	Poly (ADP-Ribose) Polymerase-1IBA 02/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2016
1	Caspase 3 (Caspase-3)IBA 02/2016
1	Baculoviral IAP Repeat-Containing 3 ProteinIBA 02/2016
1	DNA Repair EnzymesIBA 01/2016
1	Epithelial Cell Adhesion MoleculeIBA 01/2016
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Differentiation AntigensIBA 01/2016

Therapy/Procedure

10	Therapeutics 11/2020 - 07/2009
2	Radiotherapy 01/2017 - 01/2015
2	Oral Administration 06/2015 - 03/2012
1	Aftercare (After-Treatment) 12/2018
1	Drug Therapy (Chemotherapy) 01/2016